Literature DB >> 18032039

2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.

Saeed Emami1, Alireza Foroumadi, Mehraban Falahati, Ensieh Lotfali, Saeed Rajabalian, Soltan-Ahmed Ebrahimi, Shirin Farahyar, Abbas Shafiee.   

Abstract

2-Hydroxyphenacyl azole and 2-hydroxyphenacyl azolium compounds have been described as a new class of azole antifungals. Most target compounds showed significant in vitro antifungal activities against tested fungi (Candida albicans, Saccharomyces cerevisiae, Aspergillus niger, and Microsporum gypseum) with low MICs values included in the range of 0.25-32 microg/mL comparable to reference drug fluconazole. The most active compounds were also assessed for their cytotoxicity using MTT colorimetric assay on normal mouse fibroblast (NIH/3T3) cells. The results of antifungal activity and toxicity tests indicated that these compounds display antifungal activity at non-cytotoxic concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032039     DOI: 10.1016/j.bmcl.2007.10.111

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Synthesis, biological evaluation and corrosion inhibition studies of transition metal complexes of Schiff base.

Authors:  Shubham Kashyap; Sanjiv Kumar; Kalavathy Ramasamy; Siong Meng Lim; Syed Adnan Ali Shah; Hari Om; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-11-20       Impact factor: 4.215

2.  Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity.

Authors:  Seyedeh Mahdieh Hashemi; Hamid Badali; Mohammad Ali Faramarzi; Nasrin Samadi; Mohammad Hosein Afsarian; Hamid Irannejad; Saeed Emami
Journal:  Mol Divers       Date:  2014-09-03       Impact factor: 2.943

3.  1-(4-Meth-oxy-phen-yl)-2-(1H-1,2,4-triazol-1-yl)ethanone.

Authors:  Victor Kesternich; Iván Brito; Michael Bolte; Marcia Pérez-Fermann; Ronald Nelson
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-10

4.  1-(2,4-Difluoro-phen-yl)-2-(1H-1,2,4-triazol-1-yl)ethanol.

Authors:  Victor Kesternich; Ronald Nelson-González; Marcia Pérez-Fehrmann; Alejandro Cárdenas; Iván Brito
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-16

5.  Design, synthesis and biological potentials of novel tetrahydroimidazo[1,2-a]pyrimidine derivatives.

Authors:  Jyoti Rani; Monika Saini; Sanjiv Kumar; Prabhakar Kumar Verma
Journal:  Chem Cent J       Date:  2017-02-09       Impact factor: 4.215

6.  Prediction and validation of host-pathogen interactions by a versatile inference approach using Aspergillus fumigatus as a case study.

Authors:  Johannes Balkenhol; Elena Bencurova; Shishir K Gupta; Hella Schmidt; Thorsten Heinekamp; Axel Brakhage; Aparna Pottikkadavath; Thomas Dandekar
Journal:  Comput Struct Biotechnol J       Date:  2022-08-05       Impact factor: 6.155

7.  Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones.

Authors:  Adile Ayati; Mehraban Falahati; Hamid Irannejad; Saeed Emami
Journal:  Daru       Date:  2012-10-04       Impact factor: 3.117

8.  Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism.

Authors:  Ting-Lin Yen; Ming-Ping Wu; Chi-Li Chung; Wen-Bin Yang; Thanasekaran Jayakumar; Pitchairaj Geraldine; Chih-Ming Chou; Chia-Yau Chang; Wan-Jung Lu; Joen-Rong Sheu
Journal:  J Biomed Sci       Date:  2016-02-17       Impact factor: 8.410

9.  First report of Vulvovaginitis due to Cryptococcus magnus in Iran.

Authors:  Ali Ghajari; Ensieh Lotfali; Maryam Norouzi; Zahra Arab-Mazar
Journal:  Curr Med Mycol       Date:  2018-03

10.  Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.

Authors:  Titilayo O Johnson; Abayomi Emmanuel Adegboyega; Opeyemi Iwaloye; Omokehinde Abiodun Eseola; Winfried Plass; Boluwatife Afolabi; Damilare Rotimi; Eman I Ahmed; Ashraf Albrakati; Gaber E Batiha; Oluyomi Stephen Adeyemi
Journal:  J Pharmacol Sci       Date:  2021-05-23       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.